Cargando…

Breathing New Life into the Mechanisms of Platinum Resistance in Lung Adenocarcinoma

Detalles Bibliográficos
Autores principales:	Gonzalez-Rajal, Alvaro, Hastings, Jordan F., Watkins, D. Neil, Croucher, David R., Burgess, Andrew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Cell and Developmental Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225257/ https://www.ncbi.nlm.nih.gov/pubmed/32457904 http://dx.doi.org/10.3389/fcell.2020.00305

Ejemplares similares

A non-genetic, cell cycle-dependent mechanism of platinum resistance in lung adenocarcinoma
por: Gonzalez Rajal, Alvaro, et al.
Publicado: (2021)

Analysis of pulsed cisplatin signalling dynamics identifies effectors of resistance in lung adenocarcinoma
por: Hastings, Jordan F, et al.
Publicado: (2020)

The Under-Appreciated Promiscuity of the Epidermal Growth Factor Receptor Family
por: Kennedy, Sean P., et al.
Publicado: (2016)

Midkine-a Regulates the Formation of a Fibrotic Scar During Zebrafish Heart Regeneration
por: Grivas, Dimitrios, et al.
Publicado: (2021)

PRSS1 Upregulation Predicts Platinum Resistance in Ovarian Cancer Patients
por: Xing, Linan, et al.
Publicado: (2021)

Prognostic Nomograms Based on Ground Glass Opacity and Subtype of Lung Adenocarcinoma for Patients with Pathological Stage IA Lung Adenocarcinoma
por: Zhai, Wenyu, et al.
Publicado: (2021)

CAMSAP1 Mutation Correlates With Improved Prognosis in Small Cell Lung Cancer Patients Treated With Platinum-Based Chemotherapy
por: Yi, Yonglin, et al.
Publicado: (2022)

Identification of Key Genes With Differential Correlations in Lung Adenocarcinoma
por: Zhou, You, et al.
Publicado: (2021)

Identification and Validation of the Immune Subtypes of Lung Adenocarcinoma: Implications for Immunotherapy
por: Song, Yang, et al.
Publicado: (2020)

Potential Role of S-Palmitoylation in Cancer Stem Cells of Lung Adenocarcinoma
por: Zhang, Yitong, et al.
Publicado: (2021)

PARP Inhibitors: Clinical Relevance, Mechanisms of Action and Tumor Resistance
por: Rose, Maddison, et al.
Publicado: (2020)

Ferroptosis Characterization in Lung Adenocarcinomas Reveals Prognostic Signature With Immunotherapeutic Implication
por: Sun, Sijin, et al.
Publicado: (2021)

Prognostic Signature for Lung Adenocarcinoma Patients Based on Cell-Cycle-Related Genes
por: Jiang, Wei, et al.
Publicado: (2021)

Transcriptional Repression of Ferritin Light Chain Increases Ferroptosis Sensitivity in Lung Adenocarcinoma
por: Wang, Yikun, et al.
Publicado: (2021)

Single-Cell Analysis Reveals Spatial Heterogeneity of Immune Cells in Lung Adenocarcinoma
por: Wang, Youyu, et al.
Publicado: (2021)

Overexpression of PTPRN Promotes Metastasis of Lung Adenocarcinoma and Suppresses NK Cell Cytotoxicity
por: Song, Xinyue, et al.
Publicado: (2021)

Comprehensive Analysis Uncovers Prognostic and Immunogenic Characteristics of Cellular Senescence for Lung Adenocarcinoma
por: Lin, Weihao, et al.
Publicado: (2021)

Development and Validation of a Robust Ferroptosis-Related Prognostic Signature in Lung Adenocarcinoma
por: Zhang, Anran, et al.
Publicado: (2021)

Neddylation pattern indicates tumor microenvironment characterization and predicts prognosis in lung adenocarcinoma
por: Cui, Yuan, et al.
Publicado: (2022)

SUMOylation patterns and signature characterize the tumor microenvironment and predict prognosis in lung adenocarcinoma
por: Chen, Zhike, et al.
Publicado: (2023)

Genome instability-derived genes as a novel prognostic signature for lung adenocarcinoma
por: Zhang, Xu, et al.
Publicado: (2023)

Silencing of ARL14 Gene Induces Lung Adenocarcinoma Cells to a Dormant State
por: Guo, Fei, et al.
Publicado: (2019)

EGF Induces Migration Independent of EMT or Invasion in A549 Lung Adenocarcinoma Cells
por: Schelch, Karin, et al.
Publicado: (2021)

Construction of a Prognostic Immune-Related LncRNA Risk Model for Lung Adenocarcinoma
por: Li, Yue, et al.
Publicado: (2021)

Comprehensive Analysis of a Nine-Gene Signature Related to Tumor Microenvironment in Lung Adenocarcinoma
por: Zhong, Haihui, et al.
Publicado: (2021)

Histopathological Images and Multi-Omics Integration Predict Molecular Characteristics and Survival in Lung Adenocarcinoma
por: Chen, Linyan, et al.
Publicado: (2021)

Identification of Tumor Antigens and Immune Subtypes in Lung Adenocarcinoma for mRNA Vaccine Development
por: Xu, Ran, et al.
Publicado: (2022)

Identification and Validation of the Pyroptosis-Related Molecular Subtypes of Lung Adenocarcinoma by Bioinformatics and Machine Learning
por: Liu, Le-Ping, et al.
Publicado: (2021)

An Immune Panel Signature Predicts Prognosis of Lung Adenocarcinoma Patients and Correlates With Immune Microenvironment
por: Zhou, Yuan, et al.
Publicado: (2021)

The Regulators Associated With N6-Methyladenosine in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma Reveal New Clinical and Prognostic Markers
por: Tan, Shuzhen, et al.
Publicado: (2021)

A Novel Immune-Related Prognostic Model for Response to Immunotherapy and Survival in Patients With Lung Adenocarcinoma
por: Zheng, Yujia, et al.
Publicado: (2021)

ALKBH1-8 and FTO: Potential Therapeutic Targets and Prognostic Biomarkers in Lung Adenocarcinoma Pathogenesis
por: Wu, Geting, et al.
Publicado: (2021)

N6-Methyladenosine-Regulated mRNAs: Potential Prognostic Biomarkers for Patients With Lung Adenocarcinoma
por: Sun, Junjun, et al.
Publicado: (2021)

Prognosis and Immunotherapy Response With a Novel Golgi Apparatus Signature-Based Formula in Lung Adenocarcinoma
por: Jiang, Yupeng, et al.
Publicado: (2022)

An Aging-Related Gene Signature-Based Model for Risk Stratification and Prognosis Prediction in Lung Adenocarcinoma
por: Xu, Qian, et al.
Publicado: (2021)

Development and Validation of a Ferroptosis-Related Gene Signature for Overall Survival Prediction in Lung Adenocarcinoma
por: Tian, Qi, et al.
Publicado: (2021)

Identification of a Six-Gene SLC Family Signature With Prognostic Value in Patients With Lung Adenocarcinoma
por: Zhu, Jing, et al.
Publicado: (2021)

Prognostic Value of Genomic Instability of m(6)A-Related lncRNAs in Lung Adenocarcinoma
por: Li, Rui, et al.
Publicado: (2022)

Single-cell RNA sequencing reveals the cellular and molecular changes that contribute to the progression of lung adenocarcinoma
por: Liu, Bing, et al.
Publicado: (2022)

Comprehensive analysis of histone methylation modification regulators for predicting prognosis and drug sensitivity in lung adenocarcinoma
por: Ye, Ying, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_14kor5t97lnbvm2dl0pcvdjabp